Lv1
36 积分 2022-09-22 加入
Regimen-stratified Bayesian model-based meta-analysis of targeted biologics in generalised myasthenia gravis: efficacy comparison, mechanism-level class contrast, and endpoint sensitivity with model-informed trial design
5天前
已完结
Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravis
8天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
1个月前
已完结
Development and Validation of a Nomogram to Predict Minimal Symptom Expression in AChR+ gMG Patients Undergoing Efgartigimod Therapy
1个月前
已完结
Future Considerations When Considering Partial Thymectomy
2个月前
已完结
Thymectomy promotes maintained complete stable remission in myasthenia gravis
2个月前
已完结
Association Between the Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Perioperative Mortality Risk in Myasthenia Gravis Patients with Sepsis: A Retrospective Cohort Study
2个月前
已完结
Perioperative Administration of Efgartigimod in myasthenia gravis patients with Thymoma: A six-case series
2个月前
已完结
Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols
2个月前
已完结
Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
2个月前
已完结
皖公网安备34019202002308
